RedHill Announces FDA sNDA Approval for Talicia®
Provided By PR Newswire
Last update: Sep 18, 2023
FDA approves supplemental new drug application (sNDA) for Talicia, changing dosing to a simplified three times daily (TID) regimen, which may support increased patient adherence and treatment outcomes
Read more at prnewswire.com
